Press Releases
All press releases from our newswire partners
Toyota, Volvo Group and Daimler Truck AG sign binding agreement for Toyota to join cellcentric as equal shareholder
Toyota City, Japan, July 27, 2026 - (JCN Newswire) - The Volvo Group, Daimler Truck AG, cellcentric and Toyota Motor Corporation (Toyota) have signed a binding agreement for Toyota to join as an equal partner and shareholder in cellcentric, with each owner to hold one third. The agreement follows th
Pfizer and Eisai Commence Co-promotion of "NURTEC(R)" for the Acute Treatment and Prophylaxis (Preventive Treatment) of Migraine
TOKYO, July 27, 2026 - (JCN Newswire) - Pfizer Japan Inc. (Headquarters: Tokyo, President and Representative Director: Hiroo Igarashi,“Pfizer”) and Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that the companies will commence the co-promoti
Launch of a proof-of-concept experiment for a next-generation distributed AI processing infrastructure aiming to realize the Watt-Bit vision
Tokyo, Aichi and Kawasaki, Japan, July 27, 2026 - (JCN Newswire) - Nautilus Technologies, Inc., Internet Initiative Japan Inc., TEPCO Power Grid, Inc., CHUBU Electric Power Grid, Fujitsu Limited, and 1Finity Inc., a Fujitsu company and leading provider of global network solutions, today announced th
Next-generation spectator experience at KYOJO CUP: AI selects and delivers "The moment you want to see" with ultra-low latency
Tokyo, Kawasaki, and Saitama, Japan, July 27, 2026 - (JCN Newswire) - Nautilus Technologies Inc., Nomura Research Institute, Ltd., Internet Initiative Japan Inc., 1Finity Inc., a Fujitsu company and leading provider of global network solutions, Fujitsu Limited, Ghelia Inc., and M-TEC Co., Ltd. today
Sharp Acquires Vietnamese Corporation Engaged in Solar EPC And O&M Business as A Wholly Owned Subsidiary
Osaka, Japan, July 27, 2026 - (JCN Newswire) - Sharp Energy Solutions Corporation (*1) (hereinafter "SESJ") has completed the acquisition of all shares held by NSN CONSTRUCTION & ENGINEERING JSC (*2) (hereinafter "NSN") in SHARP NSN ENERGY SOLUTION JSC (hereinafter "SNES"), a joint venture estab
Collaboration Agreement announced by Sovereign Effects Partners to support GCAP
TOKYO, July 27, 2026 - (JCN Newswire) - At Farnborough International Airshow 2026, the Sovereign Effects Partners (SEPs), consisting of MBDA UK, MBDA Italia, Mitsubishi Electric, and Mitsubishi Heavy Industries signed a collaboration agreement with the intent to support the Global Combat Air Program
Chunghwa Telecom, Fujitsu and 1Finity to accelerate All-Photonics Network deployment and advance quantum technologies in Taiwan through strategic partnership
Kawasaki, Japan and Taipei, Taiwan, July 27, 2026 - (JCN Newswire) - Chunghwa Telecom Co., Ltd, Fujitsu Limited and 1Finity Inc., a Fujitsu company and leading provider of global network solutions today announced a two-year strategic partnership. This collaboration aims to further expand the applica
JCB and Fiuu Collaborate to Expand JCB Acceptance Across Southeast Asia
TOKYO // SHAH ALAM, July 23, 2026 - (JCN Newswire) - JCB International Co., Ltd., the international operations subsidiary of JCB Co., Ltd., Japan’s only international payment brand, and Fiuu, a leading fintech platform in Southeast Asia, have entered into a direct acquiring partnership co
Marketing Authorization Application for In-house Developed Insomnia Drug Lemborexant Accepted for Evaluation by European Medicines Agency (EMA)
TOKYO, July 17, 2026 - (JCN Newswire) - Eisai Co., Ltd. announced today that the European Medicines Agency (EMA) has accepted for evaluation a marketing authorization application (MAA) for its in-house-discovered and developed orexin receptor antagonist lemborexant (generic name) for the treatment o
Hitachi and NVIDIA collaborate to advance HMAX and enable end-to-end autonomous operations through the integrated control of physical AI
Developing open and sovereign-enabled multi-agent orchestration technology to optimize the overall operations at industrial sites: Enabling autonomous operations by seamlessly connecting and controlling customer facilities, equipment, and systems—including those fromthird-party manufacturers.C
Toyota's First "BE creation" Spin-Off Begins Operations in Japan
Toyota City, Japan, July 17, 2026 - (JCN Newswire) - Toyota Motor Corporation (Toyota) announced today that OneStream Co., Ltd. (OneStream), the first company to be spun off from Toyota's new-business-creation framework, "BE creation"*1, has received capital investment from three companies. Under th
MHI Advances AI Infrastructure Commercialization with U.S. Deployment of 10MW-Class Chiller and MCP Development
TOKYO, July 17, 2026 - (JCN Newswire) - Mitsubishi Heavy Industries, Ltd. (MHI) today announced deployment and strategic advancements in infrastructure technologies to meet the growing demands of high-performance computing environments, such as AI Factory.As AI Factory deployments accelerate, infras
Noetra Launches Full-Scale R&D for Japan-Developed Multimodal Foundation Model
TOKYO, July 17, 2026 - (JCN Newswire) - Noetra Corp., along with its core member companies and investors—Sony Group Corporation, SoftBank Corp., NEC Corporation, and Honda Motor Co., Ltd.—launched full-scale R&D for a Japan-developed multimodal foundation model that will serve as the
Mitsubishi Motors Launches the Xforce HEV in Indonesia
Xforce HEVTOKYO, July 17, 2026 - (JCN Newswire) - Mitsubishi Motors Corporation (hereafter, Mitsubishi Motors) announced today the start of sales for the hybrid electric vehicle (HEV) model of its Xforce compact SUV in Indonesia. The model marks Mitsubishi Motors' first HEV introduced to the Indones
Fujitsu to explore physical AI development and implementation across industries with FANUC, Yaskawa Electric, and Kawasaki Heavy Industries integrating NVIDIA technology
KAWASAKI, Japan, July 17, 2026 - (JCN Newswire) - Fujitsu Limited today announced that it has begun exploring business opportunities in the field of physical AI with leading robotics companies FANUC CORPORATION, YASKAWA Electric Corporation and Kawasaki Heavy Industries, Ltd. This initiative aims to
JCB Celebrates 30 Years of Trust, Honoring 70 Years of Japan-Philippines Friendship
TOKYO // Makati City, Philippines, July 17, 2026 - (JCN Newswire) - Japan and the Philippines established diplomatic relations in 1956, laying the foundation for decades of friendship, economic cooperation, and cultural exchange. Seventy years later, 2026 marks the Philippines–Japan Frien
TANAKA Commences Operation of "TANAKA H2 Nexus", One of Japan's Largest 500 kW Pure Hydrogen Fuel Cell Power Generation Facilities
TOKYO, July 16, 2026 - (JCN Newswire) - TANAKA PRECIOUS METAL TECHNOLOGIES Co., Ltd. (Head Office: Chuo-ku, Tokyo; Representative Director & CEO: Koichiro Tanaka), a company engaged in the industrial precious metals business of TANAKA, today announced that "TANAKA H2 Nexus", one of Japan's large
LEQEMBI(R) Real-World LEADER Study Presented at AAIC(R) 2026 Finds Over 75% of Early Alzheimer's Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treatment
TOKYO and CAMBRIDGE, Mass., July 15, 2026 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) announced today that results from the real-world Lecanemab in Early Alzheimer's Disease (LEADER) Study show that nearly 83% of early Alzheimer’s disease (AD) patients enrolled in the stu
FDA Approves LEQEMBI IQLIK(R) (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer's Disease
TOKYO and CAMBRIDGE, Mass., July 15, 2026 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB), announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application(sBLA) for a once-weekly lecanemab-irmb subcutaneous injection (U.S. brand
Eisai Presents Latest Findings Showed Etalanetug Reduced Alzheimer's Disease Tau Tangle-Specific Plasma Biomarker MTBR-tau243 at Alzheimer's Association International Conference(R) (AAIC(R)) 2026
TOKYO, July 15, 2026 - (JCN Newswire) - Eisai Co., Ltd. today announced the latest findings on etalanetug (development code: E2814) showed that this investigational anti-MTBR antibody reduced levels of plasma eMTBRtau243, a key biomarker of Alzheimer’s disease (AD) tau tangle pathology. The in